Ignite Creation Date:
2024-05-06 @ 6:31 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05696548
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-21
First Post:
2023-01-13
Brief Title:
Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer NAVIGATION
Sponsor:
National Cancer Center Hospital East
Organization:
National Cancer Center Hospital East
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-02
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-13
First Submit QC Date:
January 13 2023
Study First Post Date:
2023-01-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-19
Last Update Post Date:
2024-03-21
Last Update Post Date Type:
ACTUAL